Skip to main content

Articles

FDA Approvals
FDA Approves Monjuvi for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Read More
FDA Approvals
Tecartus First CAR T-Cell Therapy FDA Approved for Patients with Mantle-Cell Lymphoma
Read More
Perspectives
UnHealthcare
David B. Nash, MD, MBA
Read More
Infectious Diseases
COVID-Related Death Rate Tripled in Patients with Cancer versus the General Population
Phoebe Starr
Read More
Disparities in Cancer Care, Oncology
AACR’s Cancer Disparities Inaugural Report Addresses Care Inequities
Wayne Kuznar
Read More
Original Research, Practice Management
Knee Osteoarthritis Treatment Costs in the Medicare Patient Population
Gerard Malanga, MD; Faizan Niazi, PharmD; Vasco Deon Kidd, DHSc, MPH, MS, PA-C; Edmund Lau, MS; Steven M. Kurtz, PhD; Kevin L. Ong, PhD, PE; Andrew L. Concoff, MD, FACR, CAQSM
Read More
Cardiometabolic Health, Original Research
Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs for Patients with Newly Diagnosed Systolic versus Diastolic Heart Failure
Chi Nguyen, PhD; Xian Zhang, PhD; Thomas Evers, PhD; Vincent J. Willey, PharmD; Hiangkiat Tan, MS, BPharm; Thomas P. Power, MD, FACC, MRCPI
Read More
Perspectives, Infectious Diseases
Are Nursing Homes COVID-19’s “Contaminated Wells,” and Will They Receive Additional Resources?
Bruce Pyenson, FSA, MAAA, and David C. Grabowski, PhD
Read More
Perspectives, Infectious Diseases
90 Days in 2020: COVID-19 Exposes Health Equity Opportunities
Byron C. Scott, MD, MBA
Read More
Perspectives
The Idealism of Youth
David B. Nash, MD, MBA
Read More
Page 30 of 244
Results 291 - 300 of 2440